<DOC>
	<DOC>NCT00596414</DOC>
	<brief_summary>Transjugular liver catheterisation allows the measurement of hepatic venous pressure gradient (HVPG) and the sampling of liver tissue but patient's tolerance to the procedure is unknown. The aim of this study was to assess tolerance to transjugular hepatic liver biopsy with or without conscious sedation/analgesia.</brief_summary>
	<brief_title>Sedation and Analgesia for Transjugular Liver Biopsy: A Randomized Double Blind Placebo Controlled Trial</brief_title>
	<detailed_description>Consecutive patients undergoing transjugular liver biopsy will be randomly assigned to receive either placebo or midazolam (0.02 mg/kg) or 0.02 mg/kg midazolam combined with 1 mg/kg pethidine before the procedure.</detailed_description>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<mesh_term>Meperidine</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>suspected liver disease known liver disease liver transplants hepatocellular carcinoma hypersensitivity or allergy to benzodiazepines or morphinic derivatives</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>liver</keyword>
	<keyword>biopsy</keyword>
</DOC>